Obesity Paradox in Lung Cancer Prognosis: Evolving Biological Insights and Clinical Implications
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (10) , 1478-1488
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective reviewBMC Cancer, 2013
- Obesity in Cancer SurvivalAnnual Review of Nutrition, 2012
- The obesity paradox in chronic disease: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2012
- A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT StudyBMC Cancer, 2011
- Obesity and Weight Loss at Presentation of Lung Cancer are Associated with Opposite Effects on SurvivalJournal of Surgical Research, 2011
- The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomiesEuropean Journal of Cardio-Thoracic Surgery, 2011
- Waist Circumference as Compared with Body-Mass Index in Predicting Mortality from Specific CausesPLOS ONE, 2011
- Cachexia as a major underestimated and unmet medical need: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2010
- Obesity-associated improvements in metabolic profile through expansion of adipose tissueJournal of Clinical Investigation, 2007
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004